USANA Health Sciences Inc. logo

USANA Health Sciences Inc.

USNA | NYSE
Chart Builder DCF Calculator
$14.82
+$0.33 (+2.28%)
Sep 22, 2026, 2:01 PM ET · Market open

Market Data

Market Cap
$267.53M
Enterprise Value
$118.78M
Beta
0.68
Average Volume
150.03K
Shares Outstanding (Diluted)
18.49M
Shares Change YoY
-0.27%
Institutional Ownership
55.86%
Exchange
NYSE
ISIN
US90328M1071

Price Performance

Price Change 1M
6.9%
Price Change 3M
-24.5%
Price Change 6M
-15.7%
Price Change YTD
-25.5%
Price Change 1Y
-51.2%
Price Change 3Y
-75.8%
Price Change 5Y
-83.9%
1M CAGR (ann.)
-6.3%
1Y CAGR (ann.)
-53.0%
5Y CAGR (ann.)
-31.5%
All-Time CAGR
-2.0%

Valuation

PE Ratio
-11.98
Forward PE
18.95
PEG Ratio
0.07
Forward PEG
-0.09
PS Ratio
0.29
Forward PS
0.30
PB Ratio
0.49
P/FCF Ratio
90.35
P/Adj. FCF Ratio
-33.50
P/OCF Ratio
9.66
EV/Sales
0.13
EV/EBIT
40.29
EV/EBITDA
3.64
EV/FCF
40.11
Earnings Yield
-8.3%
FCF Yield
1.1%
Adj. FCF Yield
-3.0%

Financial Health

Net Cash
$148.75M
Total Debt
$14M
Cash & Short-Term Investments
$162.75M
Total Assets
$738.97M
Current Ratio
2.66
Quick Ratio
1.84
Debt / Equity Ratio
0.00
Debt / EBITDA
0.43
Debt / FCF
4.73
OCF / Debt
1.19
Interest Coverage
29.98
Altman Z-Score
3.54
Piotroski F-Score
6

Margins & Profitability

Gross Profit Margin
77.5%
Operating Profit Margin
1.4%
EBITDA Margin
3.6%
Net Profit Margin
-2.4%
FCF Margin
0.3%
Adj. FCF Margin
-0.9%
SBC / Revenue
1.2%
SBC Impact (per share)
-369.7%

Returns

Return on Assets
-3.1%
Return on Equity
-4.2%
Return on Invested Capital
-23.8%
Return on Capital Employed
2.1%
Return on Tangible Assets
-4.7%

Historical Growth (CAGR)

Revenue CAGR 3Y
-1.2%
Revenue CAGR 5Y
-6.1%
Revenue CAGR 10Y
-0.6%
EPS CAGR 3Y
-177.0%
EPS CAGR 5Y
-57.6%
EPS CAGR 10Y
-12.5%
FCF CAGR 3Y
-67.5%
FCF CAGR 5Y
-53.8%
FCF CAGR 10Y
-27.6%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
8
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Oct 27, 2026
EPS Estimate (next Q)
$0.11
EPS Growth Est (next Q)
-173.3%
Revenue Est (next Q)
$219.02M
Revenue Growth Est (next Q)
2.5%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$35
Price Target Upside
141.5%

Cash Flow

Operating Cash Flow
$16.63M
Free Cash Flow
$2.96M
Adj. Free Cash Flow
$-7.99M
FCF Per Share
$0.86
OCF Per Share
$1.50
OCF/S Ratio
3.0%

Income Statement

Revenue
$913.36M
Gross Profit
$707.36M
Operating Income
$12.35M
EBITDA
$32.59M
Net Income
$-22.16M
EPS (Diluted)
-$1.21
Revenue / Employee
$581.76K
Profit / Employee
$-14.12K
Employees
1,570

© 2026 bestshares.com. All rights reserved.